language:
Find link is a tool written by Edward Betts.searching for Decoy receptors 547 found (779 total)
alternate case: decoy receptors
Ascrinvacumab
(37 words)
[view diff]
exact match in snippet
view article
find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Transforming growth interacting factor (73 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:RTK class III (66 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLerdelimumab (84 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Somatomedin receptor (60 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLenograstim (149 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonActivin type 1 receptors (143 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:T-cell growth factor (228 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMolgramostim (120 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonTransforming growth factor (596 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFGF20 (221 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthActivin receptor (174 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:FGF22 (203 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthAlacizumab pegol (35 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthColony-stimulating factor (374 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthKeratinocyte growth factor (182 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCiliary neurotrophic factor receptor (146 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDuligotuzumab (87 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFGF15/19 (257 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthI-SMAD (63 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Futuximab (127 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthSeribantumab (124 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEmibetuzumab (117 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthImgatuzumab (124 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMetelimumab (310 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Epigen (201 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFasinumab (142 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBone morphogenetic protein receptor (329 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Patritumab (160 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDusigitumab (89 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGanitumab (130 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGlia maturation factor (115 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFlanvotumab (59 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIcrucumab (139 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPersephin (394 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTovetumab (150 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGFRA4 (80 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthRilotumumab (127 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthForetinib (183 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNesvacumab (170 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNecitumumab (199 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthErtumaxomab (118 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInsulin-like growth factor-binding protein (468 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFiclatuzumab (173 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNeuregulin 4 (413 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNorwogonin (174 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthSargramostim (876 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonRobatumumab (178 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth7,8,3'-Trihydroxyflavone (249 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFigitumumab (298 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGFRA3 (644 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthAngiopoietin receptor (224 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFulranumab (205 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPromegapoietin (181 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonNeuregulin 2 (726 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDiosmetin (145 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGrandinin (363 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMubritinib (141 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthOnartuzumab (424 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLinsitinib (286 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFGF6 (606 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTumor necrosis factor superfamily (316 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBLFresolimumab (381 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Deoxygedunin (653 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBecaplermin (418 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthK252a (282 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthThrombopoietin (1,066 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthR13 (drug) (261 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGrowth factor receptor (591 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCSPG5 (456 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLEFTY2 (237 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:FGF3 (790 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthSB-431542 (399 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Tavilermide (381 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthRadotinib (296 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthRociletinib (122 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthAncestim (257 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCenegermin (282 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLM22A-4 (300 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEutropoflavin (334 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPDGFB (434 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBone morphogenetic protein 8A (282 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Lipegfilgrastim (435 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonDalotuzumab (624 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCanertinib (241 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEphrin A3 (684 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMecasermin (272 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthINHBC (490 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Enasidenib (417 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFGF11 (171 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthSemaxanib (543 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMasitinib (608 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEphrin A4 (667 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDacomitinib (294 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthToceranib (281 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIGFBP6 (973 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGDF1 (566 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Ephrin A2 (714 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIGFBP2 (887 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTrofinetide (793 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIcotinib (668 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDacomitinib (294 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthToceranib (281 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGDF7 (465 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:MST1 (901 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTrafermin (249 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthHepatoma-derived growth factor (900 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthANA-12 (562 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthR7 (drug) (692 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthOlaratumab (913 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNeuregulin (867 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCerebrolysin (1,049 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthANGPT4 (679 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGFRA2 (gene) (812 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCixutumumab (617 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthZalutumumab (806 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthActivin type 2 receptors (583 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Cyclotraxin B (301 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMothers against decapentaplegic homolog 5 (240 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Cediranib (644 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInfigratinib (777 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLestaurtinib (1,576 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonIGFBP4 (1,224 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFGF16 (275 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFMS-like tyrosine kinase 3 ligand (724 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEvinacumab (683 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEphrin B1 (1,097 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFGF7 (1,231 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLenvatinib (934 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPDGFD (793 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIGFBP5 (904 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthArtemin (1,184 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBone morphogenetic protein 10 (529 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Motesanib (956 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTrk receptor (3,128 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthVEGF receptor (755 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTNF receptor superfamily (501 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBLMurodermin (80 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGrowth differentiation factor (1,271 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:HIOC (369 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDihexa (572 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthThrombopoietin receptor (1,526 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEphrin A1 (860 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLymphotoxin (1,459 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBLLymphotoxin beta (1,494 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBLFibroblast growth factor receptor (827 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMST1R (1,088 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthR-SMAD (304 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Des(1-3)IGF-1 (346 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFibroblast growth factor receptor (827 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBone morphogenetic protein 8B (600 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:MST1R (1,088 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNimotuzumab (803 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTGF beta receptor 2 (960 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Pegfilgrastim (844 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonFGF15 (748 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDes(1-3)IGF-1 (346 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLarotrectinib (585 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGrowth factor (1,131 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGossypetin (263 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthRegorafenib (853 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthRamucirumab (1,289 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGDF10 (590 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Tanezumab (644 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLymphotoxin beta receptor (1,508 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBLINHA (1,000 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:TGF beta signaling pathway (2,098 words) [view diff] exact match in snippet view article find links to article
or negatively, including the agonists for ligands and R-SMADs, the decoy receptors, and the ubiquitination of R-SMADs and receptors. Both chordin andMothers against decapentaplegic homolog 1 (468 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:IGFBP1 (1,045 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMatuzumab (842 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMirvetuximab soravtansine (790 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBMPR1B (524 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Ephrin A5 (1,211 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGDF3 (900 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Mothers against decapentaplegic homolog 9 (369 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:BAMBI (930 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:ANGPT2 (1,113 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthN-Acetylserotonin (1,142 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthOlmutinib (365 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthACVR1C (896 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Avapritinib (1,046 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEphrin B2 (1,320 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPHA6 (649 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBosutinib (594 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTyrosine kinase inhibitor (1,081 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGremlin (protein) (1,490 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Transforming growth factor beta superfamily (595 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:BNN-20 (572 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthSorafenib (2,617 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonAdrenomedullin (1,432 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLTBP1 (gene) (1,023 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:GDF6 (1,278 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:GFRA1 (1,493 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthVandetanib (1,148 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEpiregulin (1,149 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthC-fos-induced growth factor (1,253 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthACVR2A (1,427 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Teprotumumab (1,041 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPH receptor A1 (622 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthRipretinib (1,128 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthQuizartinib (1,251 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonLefty (protein) (1,327 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:C-fos-induced growth factor (1,253 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthACVR2B (1,346 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Renalase (1,789 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCTGF (1,537 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPHB6 (719 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTivozanib (1,189 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGDF15 (1,339 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Oncomodulin (1,183 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPDGFA (1,108 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPH receptor B2 (614 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthINHBA (1,109 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:BNN-27 (615 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNeurturin (1,477 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPDGFC (1,369 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTumor necrosis factor receptor 2 (1,356 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBLACVR1B (1,542 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:FGF12 (639 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTropomyosin receptor kinase C (3,936 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPH receptor A5 (703 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCSF2RB (192 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonNeratinib (1,299 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTGF beta 2 (910 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Ephrin B3 (1,023 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPHA8 (783 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFilgrastim (1,645 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonFGF10 (1,338 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPHB3 (933 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInterleukin 34 (283 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonInsulin-like growth factor (1,689 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthACVR1 (1,052 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Axitinib (1,126 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPoly(A)-specific ribonuclease (1,338 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:GDF5 (1,063 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Binimetinib (1,079 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLorlatinib (914 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIGF-1 LR3 (412 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthVascular endothelial growth factor B (1,558 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthSprifermin (532 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPHA7 (711 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMecasermin rinfabate (1,227 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPanitumumab (1,421 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTGF beta receptor 1 (1,618 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Pleiotrophin (1,649 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthOsimertinib (1,489 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTGF-beta receptor family (468 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Palifermin (1,288 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMothers against decapentaplegic homolog 6 (1,283 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Mothers against decapentaplegic homolog 6 (1,283 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Palifermin (1,288 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFGF9 (1,756 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPralsetinib (934 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBMPR2 (1,160 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Fibroblast growth factor 23 (1,854 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCapmatinib (1,217 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthKinase insert domain receptor (794 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBone morphogenetic protein 15 (1,674 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:INHBB (1,551 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:EPH receptor B4 (731 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTrastuzumab/hyaluronidase (703 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPH receptor A3 (1,046 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTepotinib (935 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNeurotrophic factor receptor (670 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPH receptor B1 (1,109 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTucatinib (1,683 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPlatelet-derived growth factor receptor (1,563 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFollistatin (2,169 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Nilotinib (1,667 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthErythropoietin (3,413 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPegaptanib (1,231 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTrametinib (991 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBone morphogenetic protein 2 (1,370 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:ERBB4 (1,597 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCobimetinib (1,016 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTGF beta receptor (334 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Type I cytokine receptor (514 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonType II cytokine receptor (616 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonCeritinib (1,239 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTrastuzumab deruxtecan (2,053 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBone morphogenetic protein 6 (1,159 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Pituitary adenylate cyclase-activating peptide (1,728 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLapatinib (1,479 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthADCYAP1R1 (1,555 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDecorin (1,949 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Cabozantinib (1,649 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCrizotinib (1,845 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFGF14 (879 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBone morphogenetic protein 5 (1,025 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:BMPR1A (1,490 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Betacellulin (1,755 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthSelpercatinib (1,848 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPH receptor A4 (766 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGFRα (109 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFGF4 (2,075 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCALCRL (1,689 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthAsciminib (1,212 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthACVRL1 (1,797 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Erlotinib (1,993 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthAngiopoietin 1 (1,623 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFibroblast growth factor 8 (2,175 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFibroblast growth factor receptor 4 (1,289 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPH receptor A2 (1,340 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthSelpercatinib (1,848 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFGF4 (2,075 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthAfatinib (1,126 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNeurotrophin-3 (1,816 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthAsciminib (1,212 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFGF18 (2,153 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTumor necrosis factor receptor 1 (2,200 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBLInsulin-like growth factor 2 receptor (1,664 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTGF alpha (2,040 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEntrectinib (2,105 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCiliary neurotrophic factor (1,740 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGefitinib (2,150 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEphrin (2,476 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCrenolanib (2,060 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTransforming growth factor, beta 3 (1,815 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Amivantamab (1,692 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDaved H. Fremont (329 words) [view diff] exact match in snippet view article find links to article
interactions between host cytokines and poxviruses and herpesviruses decoy receptors and neutralization of West Nile virus by therapeutic antibodies. FremontIGFBP7 (2,499 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFibroblast growth factor receptor 3 (1,955 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDecoy receptor 1 (992 words) [view diff] exact match in snippet view article find links to article
"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors". Science. 277 (5327): 818–21. doi:10.1126/science.277.5327.818. PMID 9242611Alectinib (1,424 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDecoy receptor 2 (917 words) [view diff] exact match in snippet view article find links to article
et al. (2000). "Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanomaGrowth factor receptor inhibitor (381 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMidkine (2,372 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDasatinib (1,994 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEndoglin (2,839 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:FGF19 (2,570 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEPHA10 (138 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEpidermal growth factor (1,735 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPemigatinib (1,497 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTGFBR3 (1,632 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:RET proto-oncogene (2,385 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthActivin and inhibin (2,557 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Cetuximab (2,542 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPonatinib (1,623 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthErythropoietin receptor (3,408 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPertuzumab (2,121 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInsulin-like growth factor 2 (1,928 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFibroblast growth factor (3,123 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthSunitinib (3,403 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonGDNF family of ligands (1,125 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInterleukin receptor (248 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinPlatelet-derived growth factor (2,877 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthHepatocyte growth factor (2,711 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFaralimomab (76 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonNoggin (protein) (2,327 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Thrombospondin 1 (2,343 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Brolucizumab (1,105 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMothers against decapentaplegic homolog 2 (1,925 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Interleukin-28 receptor (1,126 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonReceptor activity-modifying protein (529 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNerve growth factor (2,786 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGDF2 (2,618 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Fletikumab (117 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinNeuregulin 3 (2,559 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthAmphiregulin (3,296 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPerakizumab (67 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinHemopoietic growth factor (544 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFibroblast growth factor receptor 2 (1,748 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthVascular endothelial growth factor C (3,104 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNeurotrophic factors (1,784 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthKIT (gene) (4,118 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthVemurafenib (1,808 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthErbB (2,736 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEncorafenib (721 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNodal homolog (2,488 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Ranibizumab (2,776 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInterferon alfacon-1 (30 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonInolimomab (137 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinTGF beta 1 (2,290 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:IFNA6 (372 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonIFNA5 (407 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonCardiotrophin 1 (168 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonIFNA14 (478 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonIFNA10 (459 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonReceptor tyrosine kinase (3,078 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIFNA21 (410 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonBone morphogenetic protein 7 (2,565 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Glial cell line-derived neurotrophic factor (2,730 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInterleukin-31 receptor (36 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinThrombopoietin mimetics (76 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonTucotuzumab celmoleukin (65 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinMonokine (133 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonBasic fibroblast growth factor (2,693 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNeurotrophin (3,069 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInterleukin-22 receptor (95 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinMothers against decapentaplegic homolog 7 (2,851 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Interleukin-11 receptor (111 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinSelumetinib (2,184 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTropoflavin (2,225 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthAnrukinzumab (55 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinFaricimab (1,543 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLymphokine (184 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonHeparin-binding EGF-like growth factor (2,596 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBone morphogenetic protein (3,436 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Dabrafenib (1,122 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthProteoglycan 4 (3,645 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthRontalizumab (105 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonMothers against decapentaplegic homolog 7 (2,851 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Pascolizumab (148 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinSifalimumab (141 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonTrastuzumab emtansine (2,699 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTropomyosin receptor kinase A (3,264 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthSelumetinib (2,184 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInterferon alpha-n3 (28 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonIFNA17 (558 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonLymphotoxin alpha (2,853 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBLIFNA4 (524 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonIFNW1 (589 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonFezakinumab (176 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinIntegrin (3,930 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthAngiopoietin (2,150 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthElsilimomab (181 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinFontolizumab (144 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonGlucose-6-phosphate isomerase (3,057 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthERBB3 (2,750 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthClazakizumab (153 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinSirukumab (262 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinVascular endothelial growth factor A (3,053 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIFNA8 (451 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonInterleukin-18 receptor (183 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinTRAIL (1,335 words) [view diff] exact match in snippet view article find links to article
that have variable affinity for different death (DR4 and DR5) and decoy receptors (DCR1 and DCR2) may allow selective targeting of cancer cells by controllingGrowth differentiation factor-9 (3,324 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:FGF1 (2,307 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInterleukin-12 receptor (156 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinVarlilumab (183 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonPeficitinib (173 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonDenileukin diftitox (237 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinIngenol mebutate (1,294 words) [view diff] exact match in snippet view article find links to article
after treatment with ingenol mebutate. In addition, the interleukin decoy receptors IL1R2 and IL13RA2 were induced, resulting in a reduction in the long-termCD153 (102 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonFibroblast growth factor receptor-like 1 (842 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInterleukin-27 receptor (269 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinCerberus (protein) (2,730 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Insulin-like growth factor 1 receptor (3,603 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNintedanib (3,010 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthPegsunercept (143 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonSMAD (protein) (4,581 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Ephrin receptor (3,454 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMidostaurin (567 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonNamilumab (276 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonPacritinib (315 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonPDGFRB (3,403 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTesevatinib (381 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthNeuregulin 1 (3,921 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIFNA7 (876 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonPDGFRB (3,403 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMothers against decapentaplegic homolog 4 (3,464 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Tesevatinib (381 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthVascular endothelial growth factor (4,578 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthMothers against decapentaplegic homolog 3 (4,173 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:RAMP2 (1,169 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthLow-affinity nerve growth factor receptor (4,235 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthTropomyosin receptor kinase B (4,321 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthRAMP1 (1,146 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInterleukin-3 receptor (206 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinIL17RC (463 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinTNF receptor associated factor (136 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonIGFBP3 (4,717 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBrain-derived neurotrophic factor (5,339 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthC-Met inhibitor (3,549 words) [view diff] exact match in snippet view article find links to article
steps that regulate c-Met activation by antibodies, peptide agonists, decoy receptors and other biologic inhibitors or small molecules inhibitors. The c-MetEpoetin theta (222 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonFibroblast growth factor 21 (3,036 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGDF11 (3,974 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Fas ligand (2,581 words) [view diff] exact match in snippet view article find links to article
ISSN 0883-0185. PMID 10626245. Sheikh MS, Fornace AJ (2000). "Death and decoy receptors and p53-mediated apoptosis". Leukemia. 14 (8): 1509–1513. doi:10.1038/sjTyrosine kinase (5,251 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBrodalumab (628 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinRAMP3 (1,066 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInsulin-like growth factor 1 (4,741 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthVorsetuzumab mafodotin (116 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonGevokizumab (211 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinCytokine receptor (442 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonAdipokine (443 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonJanus kinase (974 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonHER2 (4,641 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthGlycoprotein 130 (2,202 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonDehydroepiandrosterone sulfate (2,570 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthDeucravacitinib (694 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonInterferon gamma receptor 2 (245 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonPlatelet-derived growth factor receptor A (3,354 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthAtiprimod (345 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonCD120 (337 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonSiltuximab (852 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinInterleukin-7 receptor (550 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinEpoetin beta (326 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonInterleukin-15 receptor (690 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinBenralizumab (267 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinGuselkumab (1,017 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinBasiliximab (587 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinInterleukin 28 (721 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinInterferon alfa (654 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonIL22RA1 (627 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinPrasterone sulfate (534 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthFibroblast growth factor receptor 1 (5,001 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthBriakinumab (551 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinCCRL2 (517 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonInterleukin 28 (721 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinLebrikizumab (716 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinIFNB1 (857 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonRomiplostim (542 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonInterleukin-5 receptor (848 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinAnti-Müllerian hormone (4,885 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Rilonacept (415 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinImatinib (6,513 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIFNA16 (1,013 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonAmitriptyline/perphenazine (554 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIFNA13 (1,005 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonSarilumab (1,182 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinIL36A (918 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinPertuzumab/trastuzumab/hyaluronidase (958 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthInterleukin 20 receptor, beta subunit (677 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinAnifrolumab (826 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonIL36B (844 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinInterleukin 5 (1,478 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinTNFSF9 (667 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonInterleukin 27 receptor, alpha subunit (668 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinTumor necrosis factor (6,302 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBLInterleukin-8 receptor (963 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinInterleukin-20 receptor (829 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinPeginesatide (572 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonSecukinumab (1,152 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinAlbinterferon (404 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonMyostatin (5,322 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:Interleukin 36 receptor antagonist (1,151 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinTrastuzumab (5,895 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthIL18BP (942 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinIL17RB (728 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinIL18RAP (717 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinDehydroepiandrosterone (3,935 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthEnavatuzumab (103 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonAlpha-taxilin (1,060 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinInterleukin-4 receptor (774 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinFruquintinib (524 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthWnt signaling pathway (7,427 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growthCD70 (1,089 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonInterferon-gamma receptor (868 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonInterleukin 31 (1,120 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinPitrakinra (780 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinIL-2 receptor (934 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinIL1RL2 (603 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinDeath receptor 4 (1,026 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonCanakinumab (1,263 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinInterleukin 32 (802 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa AldesleukinEctodysplasin A2 receptor (525 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) InterferonInterleukin-21 receptor (864 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin